obsolete secondary malignant neoplasm of intrapelvic lymph node

Obsolete Secondary Malignant Neoplasm of Intrapelvic Lymph Node

The term "obsolete secondary malignant neoplasm of intrapelvic lymph node" refers to a medical condition that was previously used to describe a type of cancer metastasis in the pelvic region. According to search results [9], this term is also known as "secondary malignant neoplasm of intrapelvic lymph nodes (disorder)".

Definition and Context

This obsolete term was used to classify a tumor that had spread from its original location to the lymph nodes within the pelvis. The condition was considered metastatic, meaning it had originated from another primary site and had spread to the pelvic region [10].

ICD-9-CM Code

The ICD-9-CM code for this condition was 196.6, which is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim [8]. However, it's essential to note that this code should only be used for claims with a date of service on or before September 30, 2015.

ICD-10-CM Code

The ICD-10-CM code for secondary and unspecified malignant neoplasm of intrapelvic lymph nodes is C77.5 [4]. This code became effective on October 1, 2023, and is the American ICD-10-CM version of C77.5.

References

• Search result [9]: "secondary malignant neoplasm of intrapelvic lymph node; Statements. on focus list of Wikimedia project."
• Search result [8]: "ICD-9-CM 196.6 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim..."
• Search result [4]: "The code C77.5 is VALID for claim submission."

Note: The term "obsolete secondary malignant neoplasm of intrapelvic lymph node" is no longer in use, and the ICD-9-CM code 196.6 should only be used for claims with a date of service on or before September 30, 2015.

Common Signs and Symptoms

The signs and symptoms of secondary malignant neoplasm of intrapelvic lymph nodes can vary widely, but typically include:

• Painless enlargement of lymph nodes: One or more lymph nodes in the pelvis may become enlarged or swollen, which can be a sign of cancer cells spreading to these areas [7].
• Systemic symptoms: Fever, weight loss, fatigue, or night sweats are common systemic symptoms that can occur when cancer spreads to the lymph nodes [4][9].
• Abdominal pain and discomfort: As cancer cells spread to the intrapelvic lymph nodes, they can cause abdominal pain, fevers, hematuria (blood in urine), hypertension (high blood pressure), urinary tract infection, constipation, and weight loss [9].

Other Possible Symptoms

In some cases, secondary malignant neoplasm of intrapelvic lymph nodes may also present with:

• Breathlessness: If the cancer cells spread to the lungs or cause compression on the airways, it can lead to breathlessness [11].
• Blood clots and swelling: Cancer cells spreading to blood vessels can slow down blood flow, leading to swelling in a leg or arm, and potentially causing blood clots [11].

Important Considerations

It's essential to note that these symptoms can also be caused by other conditions. A proper diagnosis from a medical professional is necessary to confirm the presence of secondary malignant neoplasm of intrapelvic lymph nodes.

References:

[4] - Symptoms such as weakness, swollen lymph nodes, local tenderness, mental disturbances, depression, etc. are a signal for an unscheduled visit to the doctor [3]. [7] - Symptoms include the painless enlargement of lymph nodes, spleen, or other immune tissue. Other symptoms include fever, weight loss, fatigue, or night sweats [7]. [9] - Abdominal pain, fevers, hematuria and/or hypertension, urinary tract infection, constipation, and weight loss are the most common signs and symptoms [9]. [11] - Symptoms of a blood clot include pain and redness or swelling in a leg or arm [11].

Diagnostic Tests for Secondary Malignant Neoplasm of Intrapelvic Lymph Nodes

The diagnosis of secondary malignant neoplasm of intrapelvic lymph nodes can be challenging, and various diagnostic tests have been employed to aid in the detection and staging of this condition. Here are some of the diagnostic tests that may be used:

• Computed Tomography (CT) scans: CT scans are a common imaging modality used to detect secondary malignant neoplasm of intrapelvic lymph nodes [5]. They can help identify enlarged or abnormal-appearing lymph nodes, which may indicate metastatic disease.
• Magnetic Resonance Imaging (MRI): MRI is another imaging modality that can be used to evaluate the pelvis and surrounding structures for signs of secondary malignant neoplasm of intrapelvic lymph nodes [3]. It is particularly useful in detecting small lesions or tumors that may not be visible on CT scans.
• Fine-needle aspiration biopsy (FNAB): FNAB is a minimally invasive procedure that involves inserting a thin needle into the affected lymph node to collect cells for examination under a microscope [2]. This test can help confirm the presence of cancerous cells in the lymph node.
• Thin-section computed tomography (CT): Thin-section CT scans have been shown to be accurate in detecting pelvic lymph nodes affected by metastatic cancer [5].
• Imaging tests: Imaging tests such as CT or MRI scans of the sinuses and neck area may also be used to look for small cancers that may have already spread to lymph nodes [6].

It's worth noting that the choice of diagnostic test will depend on various factors, including the patient's medical history, symptoms, and the suspected location and extent of the disease.

References:

[1] Fukuda H. Accuracy of thin-section computed tomography in diagnosing pelvic lymph nodes affected by metastatic cancer. [5] [2] von der Grün JM. Fine-needle aspiration biopsy of cervical masses: a review of 35 cases. [2] [3] Williams AD. CT and MR imaging of gynecologic cancers. [3] [4] Jung W. Evaluation of pelvic lymph nodes in patients with cervical carcinoma using CT, MRI, and PET/CT images. [8] [5] Fukuda H. Accuracy of thin-section computed tomography in diagnosing pelvic lymph nodes affected by metastatic cancer. [5] [6] Imaging tests for small cancers that may have already spread to lymph nodes. [6] [7] ICD-10 code for Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes. [14] [8] SNOMED CT codes for secondary lymph node cancer, metastatic malignant neoplasm to lymph node, etc. [15]

Based on the provided context, it appears that there are various treatment options available for secondary malignant neoplasm of intrapelvic lymph nodes.

• Chemotherapy: Chemotherapy is a common treatment option for cancer in the lymph nodes. It may be used alone or in combination with other treatments such as surgery or radiotherapy (see [11] and [4]).
• Targeted cancer drugs and immunotherapy: Targeted cancer drugs and immunotherapy, such as pembrolizumab, may also be used to treat cancer in the lymph nodes, especially if the tumor is PD-L1 positive (see [5] and [6]).
• Chemoradiotherapy: Chemoradiotherapy, which combines chemotherapy with radiotherapy, may be used to treat bulky pelvic lymph node metastases (see [2]).

It's worth noting that the treatment options for cancer in the lymph nodes can vary depending on individual circumstances, such as the type of primary cancer and the person's overall health. Adjuvant therapy, which is cancer treatment given after primary treatments like surgery, may also be considered to lower the chance of cancer coming back (see [7]).

References: [2] Concurrent chemoradiotherapy for bulky pelvic lymph node metastases [4] Chemotherapy and/or surgery for resistant, recurrent metastatic cervical cancer [5] Targeted cancer drugs and immunotherapy for PD-L1 positive disease [6] Atezolizumab, pembrolizumab, and cadonilimab as treatment options [7] Adjuvant therapy to lower the chance of cancer coming back [11] Treatment for cancer in the lymph nodes

Based on the provided context, it appears that differential diagnosis for adenocarcinoma in neck lymph nodes includes metastases from the lungs, breast, and gastrointestinal tracts [2]. However, when considering an obsolete secondary malignant neoplasm of intrapelvic lymph node, the differential diagnosis may involve other primary sites.

Some possible differential diagnoses for an obsolete secondary malignant neoplasm of intrapelvic lymph node could include:

• Metastases from a previously treated pelvic tumor, such as a cervical or ovarian cancer [13]
• Lymphoma or other hematological malignancies that have spread to the pelvis and lymph nodes [15]
• Secondary cancers originating from other parts of the body, such as the breast, lung, or gastrointestinal tract, which have metastasized to the intrapelvic lymph nodes

It's worth noting that the ICD-10 code C77.5 specifically refers to a secondary malignant neoplasm of intrapelvic lymph nodes [3], indicating that this is a recognized medical condition.

In terms of specific diagnoses, some possible causes of an obsolete secondary malignant neoplasm of intrapelvic lymph node could include:

• Squamous cell carcinoma or adenocarcinoma metastases from the cervix or vagina
• Metastatic disease from a previously treated ovarian or endometrial cancer
• Lymphoma or other hematological malignancies that have spread to the pelvis and lymph nodes

It's essential to consider these possibilities in conjunction with clinical presentation, imaging studies, and laboratory results to arrive at an accurate diagnosis.

References: [2] - A differential diagnosis for adenocarcinoma in neck lymph nodes includes metastases from the lungs, breast, and gastrointestinal tracts. [3] - ICD-10 code C77.5 specifically refers to a secondary malignant neoplasm of intrapelvic lymph nodes. [13] - The spread of pelvic tumors to lymph nodes is an important means of tumor dissemination. [15] - Lymphomas and second malignant neoplasms are discussed in the context of treatment and prognosis.